Mechanism of Action and Pharmacokinetics
The pharmacological target of propofol is the central nervous system. Its mechanism of action involves potentiation of the inhibitory effects of gamma-aminobutyric acid (GABA). The drug specifically binds to $\beta_2$ or $\beta_3$ subunits of GABA$_A$ receptors, leading to profound suppression of nerve impulse transmission.
Since the active substance is practically insoluble in water, the formulation is prepared exclusively as an emulsion.
Key pharmacokinetic stages:
- Metabolism: Occurs in the liver. The substance undergoes conjugation with glucuronic acid and sulfation.
- Excretion: The resulting inactive metabolites are eliminated from the body primarily by the kidneys.
Clinical Effects and Applications
The drug is administered intravenously — either intermittently (bolus) or as a continuous infusion (to maintain anesthesia).
Key characteristics of action:
- Induction of anesthesia. Develops rapidly, within 30–40 seconds. The excitation phase is minimal or absent.
- Duration. A single bolus dose maintains the effect for 3 to 10 minutes.
- Recovery. Emergence is very rapid; the patient regains consciousness approximately 4 minutes after discontinuing the drug.
A crucial feature of propofol is the absence of analgesic properties. Because the drug does not provide pain relief, it must be combined with opioid analgesics for adequate surgical intervention. Propofol is also successfully combined with inhalational anesthetics.
In addition to classic general anesthesia, the drug is used as a sedative agent. To ensure patient comfort during short procedures or mechanical ventilation, doses 2 to 5 times lower than anesthetic doses are applied.
Safety Profile and Side Effects
Propofol is generally well-tolerated, but it has a noticeable impact on vital organ systems. Administration may cause transient respiratory depression.
Cardiovascular effects:
- Causes bradycardia.
- Decreases blood pressure (BP).
- Exhibits negative inotropic action (decreases myocardial contractility).
| Advantages | Disadvantages and Risks |
|---|---|
| Best tolerability among analogs | Pain along the vein at the injection site |
| Absence of postoperative nausea and vomiting | Risk of phlebitis and thrombosis (rare) |
| No hepatic or renal toxicity | Allergic reactions possible |